AC
BSTC

Amici Capital’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Amici Capital’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,000
Closed -$487K – 167
2013
Q3 		$487K Sell
25,000
-35,000
-58% -$620K 0.02% 132
2013
Q2 		$936K Buy
+60,000
New +$965K 0.03% 107

Other funds holding BSTC

BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Amici Capital's BSTC Position: Q4 2013 in Review

Amici Capital sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2013, closing a stake of 25,000 shares — an estimated $487K sold.

Amici Capital first reported a position in BSTC in Q2 2013 and held it in 2 quarters. The position peaked at $936K in Q2 2013. 38 funds tracked by Wall St. Rank hold BSTC as of Q4 2013.

  • Amici Capital reported no remaining BioSpecifics Technologies Corp. position as of Q4 2013 after selling out during the quarter.
  • Amici Capital sold 25,000 BioSpecifics Technologies Corp. shares in Q4 2013, an estimated $487K.
  • Amici Capital first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 2 quarters.
  • Amici Capital's BioSpecifics Technologies Corp. position peaked at $936K in Q2 2013.
  • 38 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2013.

Based on Amici Capital's 13F filing for Q4 2013, filed 14 Feb 2014.